mutations and fumarate hydratase inactivation in uterine adenomyomas.

Authors:
Tuomas Heikkinen
Tuomas Heikkinen
University of Helsinki
Helsinki | Finland
Ralf Butzow
Ralf Butzow
University of Helsinki and Helsinki University Hospital
Helsinki | Finland
Annukka Pasanen
Annukka Pasanen
University of Helsinki and Helsinki University Hospital
Pia Vahteristo
Pia Vahteristo
University of Helsinki
Finland

Hum Reprod Open 2018 17;2018(4):hoy020. Epub 2018 Nov 17.

Research Programs Unit, Genome-Scale Biology Research Program and Medicum, Department of Medical and Clinical Genetics., FIN-00014 University of Helsinki, Helsinki, Finland.

Study Question: Do the uterine leiomyoma driver events - mediator complex subunit 12 () mutations, high mobility group AT-hook (HMGA2) overexpression, and fumarate hydratase (FH) inactivation - also contribute to the development of uterine adenomyomas?

Summary Answer: mutations and FH deficiency occur in a subset of uterine adenomyomas, but at lower frequencies than in leiomyomas.

What Is Known Already: Uterine adenomyomas are benign tumours with clinical features very similar to uterine leiomyomas. Mutations affecting , and account for up to 80-90% of leiomyomas, but their contribution to adenomyomas is not known.

Study Design Size Duration: Formalin-fixed paraffin-embedded adenomyoma samples from 21 patients operated on during 2012-2014 were collected at the pathology department's archives and analysed for uterine leiomyoma driver events.

Participants/materials Setting Methods: Adenomyoma diagnoses were verified by a specialized pathologist and representative areas were marked on haematoxylin-eosin slides. DNA was extracted from the tissue samples and sequenced to detect mutations in . Expression levels of HMGA2 and 2SC, a robust indirect method to detect FH inactivation, were analysed by immunohistochemistry (IHC). The coding region of was sequenced in one adenomyoma sample showing strong 2SC staining as well as in the same patient's normal tissue sample. All patients' medical histories were collected and reviewed.

Main Results And The Role Of Chance: mutation c.131G > A, p.G44D, the most common mutation in uterine leiomyomas, was identified in two samples (2/21; 9.5%). One adenomyoma displayed strong 2SC positivity and subsequent sequencing revealed a frameshift mutation c.911delC, p.P304fs in the tumour. The mutation was also present in the patient's normal tissue sample, indicating that she has a hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome. HMGA2 protein expression was normal in all adenomyomas.

Limitations Reasons For Caution: Restricted sample size limits the determination of exact mutation frequencies of the studied aberrations in adenomyomas.

Wider Implications Of The Findings: Uterine leiomyoma driver mutations do contribute to the development of some adenomyomas. We also report an adenomyoma in the context of hereditary HLRCC syndrome. Despite clinical similarities, the pathogenic mechanisms of adenomyomas and leiomyomas are likely different. Large-scale genomic analyses are warranted to elucidate the complete molecular background of adenomyomas.

Study Funding/competing Interests: This study was supported by The Academy of Finland, the Sigrid Jusélius Foundation, and the Cancer Society of Finland. The authors declare no conflict of interest.

Download full-text PDF

Source
http://dx.doi.org/10.1093/hropen/hoy020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276694PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
November 2018
4 Reads

Publication Analysis

Top Keywords

uterine adenomyomas
12
uterine leiomyoma
12
leiomyoma driver
12
uterine
9
normal tissue
8
uterine leiomyomas
8
hlrcc syndrome
8
contribute development
8
tissue sample
8
patient's normal
8
fumarate hydratase
8
strong 2sc
8
hydratase inactivation
8
adenomyomas
6
mutations
6
adenomyoma
5
mutation
5
syndrome despite
4
ihc coding
4
coding region
4

Similar Publications